compounded retatrutide Delivers Significant Hemoglobin A1C Reduction, Weight Loss in Phase 3 Type 2 Diabetes Trial Demand for Unapproved Weight-Loss Drug

Switching to another GLP-1 RA may be considered

Even coffee counts

When we look at the big picture, it looks like the deck is stacked against us

Most patients find abdomen easiest and least uncomfortable

While originally designed for Type 2 diabetes, GLP-1 drugs are now used for obesity, PCOS, cardiovascular protection, liver disease, and even neurological disorders

Last reviewed: June 16, 2026 Last updated: June 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations